Literature DB >> 2612556

Amitriptyline: linear or nonlinear kinetics in every day practice?

S Vandel1, G Bertschy, B Vandel, G Allers, R Volmat.   

Abstract

The linearity of the (AMT) kinetics of amitriptyline has been tested in 135 depressed dosed twice daily by measuring plasma. Their (AMT) and nortriptyline (NT) levels under steady-state conditions. The AMT concentration/dose ratios at low and high dosages were not significantly different and there was a linear relationship between the dose ratios and the concentration ratios. No change in the metabolic ratio (AMT/NT) was observed between the two dosages. Although the results are consistent with linear AMT kinetics, there may have been nonlinear kinetics in some patients as the ratio between the concentration/dose ratios in them at low and high dosages was greater than one. Those patients were characterized by a low concentration/dose ratio at low dosage. No clinical adverse effect appeared in the study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612556     DOI: 10.1007/bf00562551

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Substantial rise in sparteine metabolic ratio during haloperidol treatment.

Authors:  L F Gram; D Debruyne; V Caillard; J P Boulenger; J Lacotte; M Moulin; E Zarifian
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

2.  Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.

Authors:  S Vandel; B Vandel; M Sandoz; G Allers; P Bechtel; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

Review 3.  Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.

Authors: 
Journal:  Am J Psychiatry       Date:  1985-02       Impact factor: 18.112

4.  Dose-dependent kinetics of imipramine in elderly patients.

Authors:  M Bjerre; L F Gram; P Kragh-Sørensen; C B Kristensen; O L Pedersen; M Møller; P Thayssen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Debrisoquine oxidative phenotyping and psychiatric drug treatment.

Authors:  F Derenne; C Joanne; S Vandel; G Bertschy; R Volmat; P Bechtel
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.

Authors:  R G Cooke; J J Warsh; H C Stancer; K L Reed; E Persad
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

7.  Plasma levels, psychophysiological variables, and clinical response to amitriptyline.

Authors:  U Breyer-Pfaff; H J Gaertner; H Giedke
Journal:  Psychiatry Res       Date:  1982-04       Impact factor: 3.222

8.  E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.

Authors:  B Mellström; L Bertilsson; J Säwe; H U Schulz; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

9.  Nonlinear desipramine kinetics: prevalence and importance.

Authors:  J C Nelson; P I Jatlow
Journal:  Clin Pharmacol Ther       Date:  1987-06       Impact factor: 6.875

10.  Biotransformation of amitriptyline in man: interaction with phenothiazines.

Authors:  S Vandel; M Sandoz; B Vandel; B Bonin; G Allers; R Volmat
Journal:  Neuropsychobiology       Date:  1986       Impact factor: 2.328

View more
  2 in total

1.  Nonlinear kinetics of nortriptyline in every day practice.

Authors:  S Vandel; G Bertschy; B Vandel; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Nonlinear kinetics of nortriptyline in relation to nortriptyline clearance as observed during therapeutic drug monitoring.

Authors:  M Jerling; G Alván
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.